Emerging drug therapies for dementia are increasingly chosen to tackle molecular targets important in Alzheimer's disease (AD) pathobiology. Amyloid oligomers, amyloid deposits, and ...
Dementia with Lewy bodies (DLB) may not be as well-known as other forms like Alzheimer’s, but is just as devastating, so the discovery that commonly used drugs may reduce the risk of the disease ...
Researchers found that a type of diabetes medication called sodium-glucose cotransporter-2 (SGLT2) inhibitors may reduce the risk of dementia in older adults with type 2 diabetes. This class of ...